Skip to main content

$0.070 (0%)

High

$0.08

Low

$0.07

Trades

14

Turnover

$24,276

Volume

333,655
30 June 2023 at 4:10pm
Register to track BDX and receive email alerts.
Subject
BDX Ann: Strong Cohort 4 Testing Data Demonstrates Value of BCAL Test

BDX Ann: Quarterly Activities/Appendix 4C Cash Flow Report

BDX Ann: Ceasing to be a substantial holder

BDX Ann: letter to Shareholders AGM Notice

BDX Ann: Notice of Annual General Meeting/Proxy Form

BDX Ann: AGM Date and Closing Date for Director Nominations

BDX Ann: Appendix 4G and Corporate Governance Statement

BDX Ann: Annual Report to shareholders

BDX Ann: Change of Director's Interest Notice

BDX Ann: Change of Director's Interest Notice

BDX Ann: Australian Clinical Studies Launched

BDX Ann: Preliminary Final Report

BDX Ann: Market Update

BDX Ann: Becoming a substantial holder

BDX Ann: BCAL Diagnostics to List on ASX After Raising $10m in IPO

BDX Ann: BCAL Diagnostics Investor Presentation

BDX Ann: Initial Directors Interest Notice X 5

BDX Ann: Initial Substantial Shareholder Notice X 4

BDX Ann: Pre-Quotation Disclosure

BDX Ann: Top 20 Holders

BDX Ann: Distribution Schedule

BDX Ann: Securities Trading Policy

BDX Ann: Equity Incentive Plan Rules

BDX Ann: Terms & Conditions of Options

BDX Ann: Interim Report 31 December 2020

BDX Ann: Annual Report 30 June 2020

BDX Ann: Annual Report 30 June 2019

BDX Ann: Constitution

BDX Ann: Prospectus

BDX Ann: Appendix 1A and Information Form and Checklist

BDX Ann: ASX Market Release - Admission and Quotation

BDX Article: Cancer testing biz BCAL launches IPO; targets July listing

Register to track BDX and receive email alerts.